PTSD Trial, Recruiting NCT04752618 Sponsor: New York University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT04752618
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For mothers:

  • People who are already receiving preventive services at the time they are asked to take part in the study
  • People who score 28 or higher on a PTSD symptom scale, or who meet the standard diagnostic criteria for PTSD (confirm with trial site)
  • People who have at least one child between 1 and 10 years old
  • People who are the legal guardian of that child and have both physical and legal custody
  • People who can read, write, and speak English or Spanish

For clinicians:

  • People who are currently or were previously hired as a Study Clinician or Clinical Director with the Safe Mothers, Safe Children program

Who may not be able to join:

For mothers:

  • People who have had thoughts of suicide in the past month, or who have made a suicide attempt in the past year
  • People who meet the criteria for a severe substance or alcohol use disorder (6 or more symptoms on a clinical assessment) and have not been without those symptoms for at least 3 months
  • People who are currently experiencing symptoms of psychosis
  • People who have a disability that affects communication, such as deafness
  • People whose child (the child involved in the study) has a developmental condition that affects their thinking or physical abilities, such as autism
  • People whose child has shown symptoms of, or has been diagnosed with, psychosis in the past 3 months
  • People currently in a violent intimate partner or family relationship; or, if the relationship has ended, it must have ended at least 90 days ago with no plans to resume; or, if the relationship is ongoing but no violent incident has occurred, at least one year must have passed since the last incident (confirm specific circumstances with trial site)

For clinicians:

  • There are no exclusion criteria for clinicians; however, clinicians will stop completing their study-related measures when their role with Safe Mothers, Safe Children ends or if they choose to withdraw

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael A Lindsey, New York University

Phone: ‪(929) 489-1501‬

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
New York University
Registry
ClinicalTrials.gov
Start date
1 May 2021
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Post-traumatic Stress Diagnostic Scale for the DSM-5 (PDS-5); Center for Epidemiological Studies-Depression (CES-D); Dyadic Parent-Child Interaction Coding System-IV (DPICS); New foster care removals; New child abuse/neglect welfare reports; Family Preservation Services Usual Care (FPSUC) reports

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov